Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RECLAIM: MRI and Manometry in Constipation
NCT03226145Unknown
- Sponsor
- University of Nottingham
- Start
- Jul 2017
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of hyoscine butylbromide and bisacodyl in functional constipation (FC) and irritable bowel syndrome (IBS) (2 arms), sponsored by University of Nottingham. Primary endpoints: Maximal MRI Motility Index of the Ascending Colon, Percentage time occupied by cyclical propagating activity following meal and 1 more. Status: unknown.
02
Drugs
hyoscine butylbromidebisacodyl
03
Conditions
functional constipation (FC)irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT03226145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03226145.